Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A computer-controlled
MCP
joint arthrograph was developed to measure the stiffness of finger joints objectively. This was used to study the short-term (one application) and long-term (multiple applications over 6 weeks) effects of several physiotherapeutic methods on the reduction in
joint stiffness
. The techniques used were hot wax baths, pulsed ultrasound alone, wax baths plus pulsed ultrasound and exercise. In the short-term (i.e. after each application) wax plus ultrasound produced a statistically significant reduction in elastic torque range (P < 0.01) and dissipated energy (P < 0.05). However, the reductions in these stiffness parameters were temporary. Long-term no significant reductions in stiffness were measured. In other words, stiffness was reduced by each therapy session, but it then increased again before the next session. Wax, ultrasound alone or exercise produced no short- or long-term effects.
...
PMID:Changes in stiffness following short- and long-term application of standard physiotherapeutic techniques. 820 4
Osteoarthritis is a degenerative joint disease with pain and loss of joint function as major pathological features. Recent studies show that
proteasome
inhibitors reduce pain in various pathological conditions. We evaluated the effects of MG132, a reversible proteasome inhibitor on pain and joint destruction in a rat model of osteoarthritis. Osteoarthritis was induced by intraarticular injection of monosodium iodoacetate into the rat knee. Knee
joint stiffness
was scored and nociception was evaluated by mechanical pressure applied to the respective hind paw. Knee joint destruction was assessed by radiological and histological analyses. Expression of matrix metalloproteinase-3 (MMP-3) was analyzed by quantitative reverse transcription polymerase chain reaction in the knee articular cartilage. Expression of substance P (SP) and calcitonin gene-related peptide (CGRP) was studied in the dorsal root ganglia (L4-L6) by quantitative reverse transcription polymerase chain reaction and in the knee joints by immunohistochemistry. Our results indicate that daily treatment of osteoarthritic rats with MG132 significantly increases their mobility while the swelling, pain thresholds, and pathological features of the affected joints were reduced. Furthermore, the upregulated expression of MMP-3, SP, and CGRP in the arthritic rats was normalized by MG132 administration. We conclude that the proteasome inhibitor MG132 reduces pain and joint destruction, probably by involving the peripheral nervous system, and that changes in SP and CGRP expression correlate with alterations in behavioural responses. Our findings suggest that nontoxic
proteasome
inhibitors may represent a novel pharmacotherapy for osteoarthritis.
...
PMID:Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis. 2201 73
The passive stiffness at the
MCP
joint is a result of the elasticity of muscle-tendon units (MTUs) and capsule ligament complex (CLC), however, the relative contributions of these two components are unknown. We hypothesize that the MTUs provide the majority of the contributions to the
joint stiffness
by generating resistive forces when the
MCP
joint is flexed or extended. We used the work done by passive moments as a measure for the determination of the contributions to the
joint stiffness
. We conducted experiments with ten human subjects and collected joint angle and finger tip force data. The total passive moment and joint angle data were fitted with a double exponential model, and the passive moments due to the MTUs were determined by developing subject-specific models of the passive force-length change relationships. Our results show that for all the subjects, the work done by the passive moments from the MTUs is less than 50% of the total work done, and the CLC provides dominant contributions to the
joint stiffness
throughout the flexion-extension range of the joint angle. Therefore, the hypothesis that the MTUs provide the majority of the contributions to the
MCP
joint stiffness
is not supported. We also determined that the majority of the MTUs passive moment was generated by the extrinsic MTUs and the contributions of the intrinsic MTUs was negligible.
...
PMID:Muscle-tendon units provide limited contributions to the passive stiffness of the index finger metacarpophalangeal joint. 2295 36